NCT05855161Completed
Effectiveness of Rebound Therapy in Parkinson's Patients
Effectiveness of Rebound Therapy on Balance and Gait in Parkinson's Patients
Source: ClinicalTrials.gov · Last updated 28 Dec 2023
Brief summary (registry, in English)
Today, physiotherapy approaches in Parkinson's Disease (PD) form the basis of optimal treatment together with medical and surgical treatment. It is stated that various rehabilitation interventions may be effective in the field of physiotherapy. The frequently preferred among these rehabilitation interventions is the conventional treatment approach. In the conventional treatment, various exercises are preferred to improve balance and walking, as well as stretching and strengthening. On the other hand, rebound therapy require strong integration of the neuromuscular system and provide more active use of lower extremity muscle strength. Rebound therapy have been shown to be effective in improving balance in many neurological disease groups, but there is very little study on rebound therapy in PD. It was shown that rebound therapy improve proprioceptive sense, joint range of motion and quality of life. On the other hand, no study has been found showing its effect on balance and walking. Therefore, there is a need to investigate the effectiveness of rebound therapy on balance and walking.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 17 (actual)
- First submitted
- 3 May 2023
- Start date
- 10 Apr 2023
- Primary completion date
- 10 Nov 2023
- Lead sponsor
- Gazi University
- Diseases
- Parkinson disease
- NCT number
- NCT05855161
What you commit to
- Study type: Interventional
- Participants enrolled: 17
- From 10 Apr 2023 to the primary completion date, 10 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results
Who the study is looking for
- 40-80 years of age
- Having diagnosed with "Parkinson's Disease" by a specialist physician
- Having between 1-3 stages according to the Hoehn and Yahr Scale
- Mini-Mental Test score more than or equal 24
Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sivas Cumhuriyet University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation Coordinator of this site? Confirm its status | Sivas | Turkey (Türkiye) | Unknown status |
Related publications
- The effect of rebound therapy in Parkinson's disease: A single-blinded randomized controlled trial.Gait Posture · 2026 · PMID 41592453
This page is information, not medical advice. Discuss any trial with your doctor.